LCB84

LCB84 · LigaChem Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LCB84, covering 2025-09-24 to 2025-09-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors [Phase 1, Phase 2]

See pricing